{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:46:30Z","timestamp":1791924390488,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by the rapid clonal expansion of abnormally differentiated myeloid progenitor cells residing in a complex microenvironment. However, the immune cell types, status, and genome profile of the peripheral blood mononuclear cell (PBMC) microenvironment in AML patients after chemotherapy are poorly understood. In order to explore the immune microenvironment of AML patients after chemotherapy, we conducted this study for providing insights into precision medicine and immunotherapy of AML.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we used single-cell RNA sequencing (scRNA-seq) to analyse the PBMC microenvironment from five AML patients treated with different chemotherapy regimens and six healthy donors. We compared the cell compositions in AML patients and healthy donors, and performed gene set enrichment analysis (GSEA), CellPhoneDB, and copy number variation (CNV) analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using scRNA-seq technology, 91,772 high quality cells of 44,950 PBMCs from AML patients and 46,822 PBMCs from healthy donors were classified as 14 major cell clusters. Our study revealed the sub-cluster diversity of T cells, natural killer (NK) cells, monocytes, dendritic cells (DCs), and haematopoietic stem cell progenitors (HSC-Prog) in AML patients under chemotherapy. NK cells and monocyte-DCs showed significant changes in transcription factor expression and chromosome copy number variation (CNV). We also observed significant heterogeneity in CNV and intercellular interaction networks in HSC-Prog cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results elucidated the PBMC single-cell landscape and provided insights into precision medicine and immunotherapy for treating AML.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13402-023-00853-2","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:02:21Z","timestamp":1692860541000},"page":"97-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy"],"prefix":"10.1007","volume":"47","author":[{"given":"Xuqiao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"853_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13045-020-00992-1","volume":"13","author":"MT Gebru","year":"2020","unstructured":"M.T. Gebru, H.G. Wang, Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia. J. Hematol. Oncol. 13, 155 (2020). https:\/\/doi.org\/10.1186\/s13045-020-00992-1","journal-title":"J. Hematol. Oncol."},{"key":"853_CR2","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"I. De Kouchkovsky, M. Abdul-Hay, Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 6, e441 (2016). https:\/\/doi.org\/10.1038\/bcj.2016.50","journal-title":"Blood Cancer J."},{"key":"853_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1126\/science.1183424","volume":"328","author":"XW Zhang","year":"2010","unstructured":"X.W. Zhang, X.J. Yan, Z.R. Zhou et al., Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328, 240\u2013243 (2010). https:\/\/doi.org\/10.1126\/science.1183424","journal-title":"Science"},{"key":"853_CR4","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/cancers12113225","volume":"12","author":"M Stanchina","year":"2020","unstructured":"M. Stanchina, D. Soong, B. Zheng-Lin et al., Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers 12, 3225 (2020). https:\/\/doi.org\/10.3390\/cancers12113225","journal-title":"Cancers"},{"key":"853_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","volume":"127","author":"JJ Cornelissen","year":"2016","unstructured":"J.J. Cornelissen, D. Blaise, Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood 127, 62\u201370 (2016). https:\/\/doi.org\/10.1182\/blood-2015-07-604546","journal-title":"Blood"},{"key":"853_CR6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"P. van Galen, V. Hovestadt, I.M. Wadsworth et al., Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.01.031","journal-title":"Cell"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","volume":"25","author":"C Toffalori","year":"2019","unstructured":"C. Toffalori, L. Zito, V. Gambacorta et al., Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat. Med. 25, 603\u2013611 (2019). https:\/\/doi.org\/10.1038\/s41591-019-0400-z","journal-title":"Nat. Med."},{"key":"853_CR8","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41467-019-11591-1","volume":"10","author":"AA Petti","year":"2019","unstructured":"A.A. Petti, S.R. Williams, C.A. Miller et al., A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat. Commun. 10, 3660 (2019). https:\/\/doi.org\/10.1038\/s41467-019-11591-1","journal-title":"Nat. Commun."},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/leu.2016.311","volume":"31","author":"W Piao","year":"2017","unstructured":"W. Piao, D. Chau, L.M. Yue et al., Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma. Leukemia 31, 522\u2013526 (2017). https:\/\/doi.org\/10.1038\/leu.2016.311","journal-title":"Leukemia"},{"key":"853_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/10428194.2017.1344905","volume":"59","author":"P Boddu","year":"2018","unstructured":"P. Boddu, H. Kantarjian, G. Garcia-Manero et al., The emerging role of immune checkpoint based approaches in AML and MDS. Leuk. Lymphoma 59, 790\u2013802 (2018). https:\/\/doi.org\/10.1080\/10428194.2017.1344905","journal-title":"Leuk. Lymphoma"},{"key":"853_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fphar.2019.00609","volume":"10","author":"D Liao","year":"2019","unstructured":"D. Liao, M. Wang, Y. Liao et al., A review of efficacy and safety of checkpoint inhibitor for the treatment of acute myeloid Leukemia. Front. Pharmacol. 10, 609 (2019). https:\/\/doi.org\/10.3389\/fphar.2019.00609","journal-title":"Front. Pharmacol."},{"key":"853_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.exphem.2016.08.010","volume":"44","author":"B Yanagisawa","year":"2016","unstructured":"B. Yanagisawa, G. Ghiaur, B.D. Smith et al., Translating leukemia stem cells into the clinical setting: harmonizing the heterogeneity. Exp. Hematol. 44, 1130\u20131137 (2016). https:\/\/doi.org\/10.1016\/j.exphem.2016.08.010","journal-title":"Exp. Hematol."},{"key":"853_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1172\/JCI71264","volume":"124","author":"B Bartholdy","year":"2014","unstructured":"B. Bartholdy, M. Christopeit, B. Will et al., HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia. J. Clin. Invest. 124, 1158\u20131167 (2014). https:\/\/doi.org\/10.1172\/JCI71264","journal-title":"J. Clin. Invest."},{"key":"853_CR14","doi-asserted-by":"publisher","first-page":"890178","DOI":"10.1155\/2012\/890178","volume":"2012","author":"ZC Ding","year":"2012","unstructured":"Z.C. Ding, G. Zhou, Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects. Clin. Dev. Immunol. 2012, 890178 (2012). https:\/\/doi.org\/10.1155\/2012\/890178","journal-title":"Clin. Dev. Immunol."},{"key":"853_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"L. Zhang, X. Yu, L. Zheng et al., Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018). https:\/\/doi.org\/10.1038\/s41586-018-0694-x","journal-title":"Nature"},{"key":"853_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R Forster","year":"2008","unstructured":"R. Forster, A.C. Davalos-Misslitz, A. Rot, CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362\u2013371 (2008). https:\/\/doi.org\/10.1038\/nri2297","journal-title":"Nat. Rev. Immunol."},{"key":"853_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","volume":"53","author":"FD Pais","year":"2020","unstructured":"F.D. Pais, J.G. Silva, T. Wyss et al., Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity 53, 985\u20131000 (2020). https:\/\/doi.org\/10.1016\/j.immuni.2020.09.005","journal-title":"Immunity"},{"key":"853_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","volume":"118","author":"C Berger","year":"2008","unstructured":"C. Berger, M.C. Jensen, P.M. Lansdorp et al., Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118, 294\u2013305 (2008). https:\/\/doi.org\/10.1172\/JCI32103","journal-title":"J. Clin. Invest."},{"key":"853_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","volume":"28","author":"J Zhou","year":"2005","unstructured":"J. Zhou, M.E. Dudley, S.A. Rosenberg et al., Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J. Immunother. 28, 53\u201362 (2005). https:\/\/doi.org\/10.1097\/00002371-200501000-00007","journal-title":"J. Immunother."},{"key":"853_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.immuni.2020.11.005","volume":"54","author":"DA Mogilenko","year":"2021","unstructured":"D.A. Mogilenko, O. Shpynov, P.S. Andhey et al., Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging. Immunity 54, 99\u2013115 (2021). https:\/\/doi.org\/10.1016\/j.immuni.2020.11.005","journal-title":"Immunity"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"104118","DOI":"10.1016\/j.cellimm.2020.104118","volume":"353","author":"H Lu","year":"2020","unstructured":"H. Lu, H. Wang, L. Yan et al., Overexpression of early T cell differentiation-specific transcription factors transforms the terminally differentiated effector T cells into less differentiated state. Cell. Immunol. 353, 104118 (2020). https:\/\/doi.org\/10.1016\/j.cellimm.2020.104118","journal-title":"Cell. Immunol."},{"key":"853_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ni.3076","volume":"16","author":"S Shrestha","year":"2015","unstructured":"S. Shrestha, K. Yang, C. Guy et al., Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16, 178\u2013187 (2015). https:\/\/doi.org\/10.1038\/ni.3076","journal-title":"Nat. Immunol."},{"key":"853_CR23","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1182\/blood-2011-07-365817","volume":"118","author":"C Ustun","year":"2011","unstructured":"C. Ustun, J.S. Miller, D.H. Munn et al., Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 118, 5084\u20135095 (2011). https:\/\/doi.org\/10.1182\/blood-2011-07-365817","journal-title":"Blood"},{"key":"853_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cdd.2014.89","volume":"22","author":"C Riether","year":"2015","unstructured":"C. Riether, C.M. Schurch, A.F. Ochsenbein, Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ. 22, 187\u2013198 (2015). https:\/\/doi.org\/10.1038\/cdd.2014.89","journal-title":"Cell Death Differ."},{"key":"853_CR25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41375-019-0693-4","volume":"34","author":"JF Zeidner","year":"2020","unstructured":"J.F. Zeidner, H.A. Knaus, A.M. Zeidan et al., Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS. Leukemia 34, 1563\u20131576 (2020). https:\/\/doi.org\/10.1038\/s41375-019-0693-4","journal-title":"Leukemia"},{"key":"853_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood.2019001963","volume":"135","author":"BY Chen","year":"2020","unstructured":"B.Y. Chen, J. Song, C.L. Hu et al., SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. Blood 135, 2271\u20132285 (2020). https:\/\/doi.org\/10.1182\/blood.2019001963","journal-title":"Blood"},{"key":"853_CR27","doi-asserted-by":"publisher","first-page":"7399","DOI":"10.1158\/0008-5472.CAN-04-1865","volume":"64","author":"E Tiacci","year":"2004","unstructured":"E. Tiacci, S. Pileri, A. Orleth et al., PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res. 64, 7399\u20137404 (2004). https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1865","journal-title":"Cancer Res."},{"key":"853_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1101\/gad.337196.120","volume":"34","author":"N Brockdorff","year":"2020","unstructured":"N. Brockdorff, J.S. Bowness, G. Wei, Progress toward understanding chromosome silencing by Xist RNA. Genes Dev. 34, 733\u2013744 (2020). https:\/\/doi.org\/10.1101\/gad.337196.120","journal-title":"Genes Dev."},{"key":"853_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41590-020-0758-6","volume":"21","author":"SS Ng","year":"2020","unstructured":"S.S. Ng, R.F. De Labastida, J. Yan et al., The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation. Nat. Immunol. 21, 1205\u20131218 (2020). https:\/\/doi.org\/10.1038\/s41590-020-0758-6","journal-title":"Nat. Immunol."},{"key":"853_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nm.4023","volume":"22","author":"F Dotiwala","year":"2016","unstructured":"F. Dotiwala, S. Mulik, R.B. Polidoro et al., Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites. Nat. Med. 22, 210\u2013216 (2016). https:\/\/doi.org\/10.1038\/nm.4023","journal-title":"Nat. Med."},{"key":"853_CR31","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1038\/ncomms9306","volume":"6","author":"JP Bottcher","year":"2015","unstructured":"J.P. Bottcher, M. Beyer, F. Meissner et al., Functional classification of memory CD8+ T cells by CX3CR1 expression. Nat. Commun. 6, 8306 (2015). https:\/\/doi.org\/10.1038\/ncomms9306","journal-title":"Nat. Commun."},{"key":"853_CR32","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.1038\/ncomms11733","volume":"7","author":"L Hartmann","year":"2016","unstructured":"L. Hartmann, S. Dutta, S. Opatz et al., ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. Nat. Commun. 7, 11733 (2016). https:\/\/doi.org\/10.1038\/ncomms11733","journal-title":"Nat. Commun."},{"key":"853_CR33","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/1873-3468.13521","volume":"593","author":"M Conte","year":"2019","unstructured":"M. Conte, C. Dell\u2019Aversana, G. Sgueglia et al., HDAC2-dependent miRNA signature in acute myeloid leukemia. FEBS Lett. 593, 2574\u20132584 (2019). https:\/\/doi.org\/10.1002\/1873-3468.13521","journal-title":"FEBS Lett."},{"key":"853_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","volume":"9","author":"BL Salomon","year":"2018","unstructured":"B.L. Salomon, M. Leclerc, J. Tosello et al., Tumor necrosis factor alpha and regulatory T cells in oncoimmunology. Front. Immunol. 9, 444 (2018). https:\/\/doi.org\/10.3389\/fimmu.2018.00444","journal-title":"Front. Immunol."},{"key":"853_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12967-020-02491-w","volume":"18","author":"X Wang","year":"2020","unstructured":"X. Wang, J. Duanmu, X. Fu et al., Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment. J. Transl. Med. 18, 324 (2020). https:\/\/doi.org\/10.1186\/s12967-020-02491-w","journal-title":"J. Transl. Med."},{"key":"853_CR36","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.3892\/ol.2017.6076","volume":"13","author":"Y Xiao","year":"2017","unstructured":"Y. Xiao, T. Deng, C. Su et al., MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol. Lett. 13, 4986\u20134994 (2017). https:\/\/doi.org\/10.3892\/ol.2017.6076","journal-title":"Oncol. Lett."},{"key":"853_CR37","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"I. Nepstad, K.J. Hatfield, I.S. Gronningsaeter et al., The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int. J. Mol. Sci. 21, 2907 (2020). https:\/\/doi.org\/10.3390\/ijms21082907","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-020-00574-8","volume":"18","author":"A Crinier","year":"2021","unstructured":"A. Crinier, P.Y. Dumas, B. Escaliere et al., Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cell. Mol. Immunol. 18, 1290\u20131304 (2021). https:\/\/doi.org\/10.1038\/s41423-020-00574-8","journal-title":"Cell. Mol. Immunol."},{"key":"853_CR39","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/onc.2013.170","volume":"33","author":"D Cui","year":"2014","unstructured":"D. Cui, L. Li, H. Lou et al., The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene 33, 2225\u20132235 (2014). https:\/\/doi.org\/10.1038\/onc.2013.170","journal-title":"Oncogene"},{"key":"853_CR40","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"R.Y. Ebright, S. Lee, B.S. Wittner et al., Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science 367, 1468\u20131473 (2020). https:\/\/doi.org\/10.1126\/science.aay0939","journal-title":"Science"},{"key":"853_CR41","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41375-019-0504-y","volume":"33","author":"R Karjalainen","year":"2019","unstructured":"R. Karjalainen, M. Liu, A. Kumar et al., Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML. Leukemia 33, 2548\u20132553 (2019). https:\/\/doi.org\/10.1038\/s41375-019-0504-y","journal-title":"Leukemia"},{"key":"853_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/abt\/tby002","volume":"1","author":"D Zahavi","year":"2018","unstructured":"D. Zahavi, D. AlDeghaither, A. O\u2019Connell et al., Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy. Antib. Ther. 1, 7\u201312 (2018). https:\/\/doi.org\/10.1093\/abt\/tby002","journal-title":"Antib. Ther."},{"key":"853_CR43","first-page":"12297","volume":"8","author":"XQ Jiang","year":"2015","unstructured":"X.Q. Jiang, L. Zhang, H.A. Liu et al., Expansion of CD14+CD16+ monocytes is related to acute leukemia. Int. J. Clin. Exp. Med. 8, 12297\u201312306 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"key":"853_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","volume":"53","author":"KL Wong","year":"2012","unstructured":"K.L. Wong, W.H. Yeap, J.J. Tai et al., The three human monocyte subsets: implications for health and disease. Immunol. Res. 53, 41\u201357 (2012). https:\/\/doi.org\/10.1007\/s12026-012-8297-3","journal-title":"Immunol. Res."},{"key":"853_CR45","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"K.L. Wong, J.J. Tai, W.C. Wong et al., Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118, e16\u2013e31 (2011). https:\/\/doi.org\/10.1182\/blood-2010-12-326355","journal-title":"Blood"},{"key":"853_CR46","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1080\/10428194.2020.1742898","volume":"61","author":"Y Zhang","year":"2020","unstructured":"Y. Zhang, L. Xiao, Identification and validation of a prognostic 8-gene signature for acute myeloid leukemia. Leuk. Lymphoma 61, 1981\u20131988 (2020). https:\/\/doi.org\/10.1080\/10428194.2020.1742898","journal-title":"Leuk. Lymphoma"},{"key":"853_CR47","doi-asserted-by":"publisher","first-page":"eaay3994","DOI":"10.1126\/sciimmunol.aay3994","volume":"5","author":"MM Miller","year":"2020","unstructured":"M.M. Miller, P.S. Patel, K. Bao et al., BATF acts as an essential regulator of IL-25-responsive migratory ILC2 cell fate and function. Sci. Immunol. 5, eaay3994 (2020). https:\/\/doi.org\/10.1126\/sciimmunol.aay3994","journal-title":"Sci. Immunol."},{"key":"853_CR48","doi-asserted-by":"publisher","first-page":"eaaz8154","DOI":"10.1126\/sciimmunol.aaz8154","volume":"5","author":"Q Liu","year":"2020","unstructured":"Q. Liu, M.H. Kim, L. Friesen et al., BATF regulates innate lymphoid cell hematopoiesis and homeostasis. Sci. Immunol. 5, eaaz8154 (2020). https:\/\/doi.org\/10.1126\/sciimmunol.aaz8154","journal-title":"Sci. Immunol."},{"key":"853_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1742-7843.2012.00904.x","volume":"111","author":"KI Kim","year":"2012","unstructured":"K.I. Kim, T.K. Kim, I.W. Kim et al., Copy number variations in normal karyotype acute myeloid leukaemia and their association with treatment response. Basic Clin. Pharmacol. Toxicol. 111, 317\u2013324 (2012). https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00904.x","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"853_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/0008-5472.CAN-18-2932","volume":"80","author":"K Sachs","year":"2020","unstructured":"K. Sachs, A.L. Sarver, K.E. Noble-Orcutt et al., Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia. Cancer Res. 80, 458\u2013470 (2020). https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2932","journal-title":"Cancer Res."},{"key":"853_CR51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.stem.2016.08.003","volume":"19","author":"LA Crews","year":"2016","unstructured":"L.A. Crews, L. Balaian, S.N. Delos et al., RNA splicing modulation selectively impairs leukemia stem cell maintenance in secondary human AML. Cell Stem Cell 19, 599\u2013612 (2016). https:\/\/doi.org\/10.1016\/j.stem.2016.08.003","journal-title":"Cell Stem Cell"},{"key":"853_CR52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2013-07-517953","volume":"123","author":"A Stoddart","year":"2014","unstructured":"A. Stoddart, A.A. Fernald, J. Wang et al., Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice. Blood 123, 1069\u20131078 (2014). https:\/\/doi.org\/10.1182\/blood-2013-07-517953","journal-title":"Blood"},{"key":"853_CR53","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1158\/1078-0432.CCR-20-2272","volume":"26","author":"H Sill","year":"2020","unstructured":"H. Sill, A. Zebisch, D. Haase, Acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations - a distinct stem cell disorder. Clin. Cancer. Res. 26, 5304\u20135309 (2020). https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2272","journal-title":"Clin. Cancer. Res."},{"key":"853_CR54","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"M. Efremova, M. Vento-Tormo, S.A. Teichmann et al., Cell PhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020). https:\/\/doi.org\/10.1038\/s41596-020-0292-x","journal-title":"Nat. Protoc."},{"key":"853_CR55","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/ijms18061115","volume":"18","author":"P Tsapogas","year":"2017","unstructured":"P. Tsapogas, C.J. Mooney, G. Brown et al., The cytokine Flt3-ligand in normal and malignant hematopoiesis. Int. J. Mol. Sci. 18, 1115 (2017). https:\/\/doi.org\/10.3390\/ijms18061115","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR56","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.celrep.2016.07.058","volume":"16","author":"KR Katsumura","year":"2016","unstructured":"K.R. Katsumura, I.M. Ong, A.W. DeVilbiss et al., GATA factor-dependent positive-feedback circuit in acute myeloid leukemia cells. Cell Rep. 16, 2428\u20132441 (2016). https:\/\/doi.org\/10.1016\/j.celrep.2016.07.058","journal-title":"Cell Rep."},{"key":"853_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-020-00947-6","volume":"13","author":"B Salik","year":"2020","unstructured":"B. Salik, M.J. Smyth, K. Nakamura, Targeting immune checkpoints in hematological malignancies. J. Hematol. Oncol. 13, 111 (2020). https:\/\/doi.org\/10.1186\/s13045-020-00947-6","journal-title":"J. Hematol. Oncol."},{"key":"853_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-017-0474-3","volume":"10","author":"CY Ok","year":"2017","unstructured":"C.Y. Ok, K.H. Young, Checkpoint inhibitors in hematological malignancies. J. Hematol. Oncol. 10, 103 (2017). https:\/\/doi.org\/10.1186\/s13045-017-0474-3","journal-title":"J. Hematol. Oncol."},{"key":"853_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/bjh.16358","volume":"188","author":"A Ghosh","year":"2020","unstructured":"A. Ghosh, P. Barba, M.A. Perales, Checkpoint inhibitors in AML: are we there yet? Br. J. Haematol. 188, 159\u2013167 (2020). https:\/\/doi.org\/10.1111\/bjh.16358","journal-title":"Br. J. Haematol."},{"key":"853_CR60","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/s41388-020-1239-y","volume":"39","author":"Z Li","year":"2020","unstructured":"Z. Li, M. Philip, P.B. Ferrell, Alterations of T-cell-mediated immunity in acute myeloid leukemia. Oncogene 39, 3611\u20133619 (2020). https:\/\/doi.org\/10.1038\/s41388-020-1239-y","journal-title":"Oncogene"},{"key":"853_CR61","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/cncr.31896","volume":"125","author":"P Williams","year":"2019","unstructured":"P. Williams, S. Basu, G. Garcia-Manero et al., The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer 125, 1470\u20131481 (2019). https:\/\/doi.org\/10.1002\/cncr.31896","journal-title":"Cancer"},{"key":"853_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"A. Butler, P. Hoffman, P. Smibert et al., Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018). https:\/\/doi.org\/10.1038\/nbt.4096","journal-title":"Nat. Biotechnol."},{"key":"853_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"C.S. McGinnis, L.M. Murrow, Z.J. Gartner, DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 (2019). https:\/\/doi.org\/10.1016\/j.cels.2019.03.003","journal-title":"Cell Syst."},{"key":"853_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"S. Hanzelmann, R. Castelo, J. Guinney, GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013). https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinformatics"},{"key":"853_CR65","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"B. Van de Sande, C. Flerin, K. Davie et al., A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276 (2020). https:\/\/doi.org\/10.1038\/s41596-020-0336-2","journal-title":"Nat. Protoc."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-023-00853-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T16:00:59Z","timestamp":1709049659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-023-00853-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1007\/s13402-023-00853-2","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"31 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}